Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Author is Jensen, Michael C  [Clear All Filters]
B
Berger, C, Turtle CJ, Jensen MC, Riddell SR.  2009.  Adoptive transfer of virus-specific and tumor-specific T cell immunity.. Current opinion in immunology. 21(2):224-32. Abstract
Berger, C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR.  2008.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.. The Journal of clinical investigation. 118(1):294-305. Abstract
Berger, C, Berger M, Hackman RC, Gough M, Elliott C, Jensen MC, Riddell SR.  2009.  Safety and immunologic effects of IL-15 administration in nonhuman primates.. Blood. 114(12):2417-26. Abstract
Brown, CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, Todorov I, Shih C-C, Badie B, Hudecek M, Riddell SR et al..  2009.  Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.. Cancer research. 69(23):8886-93. Abstract
H
Hudecek, M, Lupo-Stanghellini M-T, Kosasih PL, Sommermeyer D, Jensen MC, Rader C, Riddell SR.  2013.  Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Hudecek, M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang W-C, Greisman HA et al..  2010.  The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.. Blood. 116(22):4532-41. Abstract
Hunter, MR, Prosser ME, Mahadev V, Wang X, Aguilar B, Brown CE, Forman SJ, Jensen MC.  2013.  Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes.. Molecular immunology. 56(1-2):1-11. Abstract
J
James, SE, Greenberg PD, Jensen MC, Lin Y, Wang J, Till BG, Raubitschek AA, Forman SJ, Press OW.  2008.  Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane.. Journal of immunology (Baltimore, Md. : 1950). 180(10):7028-38. Abstract
James, SE, Greenberg PD, Jensen MC, Lin Y, Wang J, Budde LE, Till BG, Raubitschek AA, Forman SJ, Press OW.  2010.  Mathematical modeling of chimeric TCR triggering predicts the magnitude of target lysis and its impairment by TCR downmodulation.. Journal of immunology (Baltimore, Md. : 1950). 184(8):4284-94. Abstract
James, SE, Orgun NN, Tedder TF, Shlomchik MJ, Jensen MC, Lin Y, Greenberg PD, Press OW.  2009.  Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice.. Blood. 114(27):5454-63. Abstract
R
Riddell, SR, Jensen MC, June CH.  2012.  Chimeric Antigen Receptor Modified T Cells - Clinical Translation in Stem Cell Transplantation and Beyond.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
T
Terakura, S, Yamamoto TN, Gardner RA, Turtle CJ, Jensen MC, Riddell SR.  2012.  Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells.. Blood. 119(1):72-82. Abstract
Till, BG, Jensen MC, Wang J, Chen EY, Wood BL, Greisman HA, Qian X, James SE, Raubitschek A, Forman SJ et al..  2008.  Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.. Blood. 112(6):2261-71. Abstract
Till, BG, Jensen MC, Wang J, Qian X, Gopal AK, Maloney DG, Lindgren CG, Lin Y, Pagel JM, Budde LE et al..  2012.  CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.. Blood. 119(17):3940-50. Abstract
Turtle, CJ, Hudecek M, Jensen MC, Riddell SR.  2012.  Engineered T cells for anti-cancer therapy.. Current opinion in immunology. Abstract
W
Wang, X, Chang W-C, Wong CLW, Colcher D, Sherman M, Ostberg JR, Forman SJ, Riddell SR, Jensen MC.  2011.  A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells.. Blood. 118(5):1255-63. Abstract
Wang, X, Naranjo A, Brown CE, Bautista C, Wong CLW, Chang W-C, Aguilar B, Ostberg JR, Riddell SR, Forman SJ et al..  2012.  Phenotypic and Functional Attributes of Lentivirus-modified CD19-specific Human CD8+ Central Memory T Cells Manufactured at Clinical Scale.. Journal of immunotherapy (Hagerstown, Md. : 1997). 35(9):689-701. Abstract
Wang, X, Berger C, Wong CLW, Forman SJ, Riddell SR, Jensen MC.  2011.  Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice.. Blood. 117(6):1888-98. Abstract